Statins are one of the main cholesterol-lowering drugs and, statistically, one in four American citizens over the age of 45 takes them to lower their cholesterol levels.
This industry is worth approximately $30 billion, but it is also associated with countless side effects such as chronic fatigue, anemia, liver dysfunction, Parkinson's disease, diabetes, Alzheimer's disease, acidosis, thyroid disorders, and cancer.
There is a film, "29 Billion Reasons to Lie About Cholesterol" by Justin Smith, in which he reported:
"Between 1994 and 2006, men aged 65 to 74 who faced an increase in cholesterol levels lowered them from 87% to 54%, but this same group began to suffer from heart disease, and the rate of coronary heart disease remained the same. There were also other groups where people with high cholesterol levels had decreased while the rate of heart disease had increased."
According to numerous studies, cholesterol-lowering drugs increase the risk of cancer, and in the Journal of the American Medical Association, there was a report dating back to 1996:
"The use of lipid-lowering drugs (statins and fibrates) only increased the risk of cancer in rodents. In a few cases, the animals were exposed to levels comparable to those prescribed for humans.
Careful post-marketing surveillance and long-term clinical trials were needed over the following decades to determine whether the drugs prescribed to lower cholesterol levels are actually the ones that trigger cancer in humans. During the research, it was quickly found that these lipid-lowering drugs, particularly statins and fibrates, should not be used in humans or animals, especially in patients at high risk of coronary heart disease."
Continue reading by clicking the ( NEXT 》 ) button below!
